Literature DB >> 12555230

Possible parent-of-origin effect of Dopa decarboxylase in susceptibility to bipolar affective disorder.

A D Børglum1, G Kirov, N Craddock, O Mors, W Muir, V Murray, I McKee, D A Collier, H Ewald, M J Owen, D Blackwood, T A Kruse.   

Abstract

Dopa decarboxylase (DDC) catalyses the synthesis of both dopamine and serotonin as well as trace amines suggested to possess neuromodulating capabilities. We have previously reported evidence suggesting an association between DDC and bipolar affective disorder (BPAD) [Børglum et al., 1999]. To further investigate the possible role of DDC in BPAD, we analyzed a 1- and a 4-bp deletion variant-both of putative functional significance-in two new samples: a case-control sample with 140 cases and 204 controls, and 100 case-parents trios. We also tested for association in subjects with familial disease in both the new and the previously investigated samples. The previously reported association was not replicated in either of the new samples. However, a preponderance of the 1-bp deletion was increased by analysis of the familial cases separately for all case-control samples investigated, indicating a possible association with familial disease (combined analysis, P = 0.02). In the trio sample, a preferential paternal transmission of the 4-bp deletion was observed (P = 0.006). DDC is located next to the imprinted gene GRB10, which is expressed specifically from the paternal allele in fetal brains. Increased transmission of paternal DDC alleles has also been suggested in attention deficit hyperactivity disorder. We suggest that DDC might confer susceptibility to BPAD predominantly when paternally transmitted. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12555230     DOI: 10.1002/ajmg.b.10030

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

1.  A linkage search for joint panic disorder/bipolar genes.

Authors:  Mark W Logue; Martina Durner; Gary A Heiman; Susan E Hodge; Steven P Hamilton; James A Knowles; Abby J Fyer; Myrna M Weissman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-12-05       Impact factor: 3.568

2.  Epigenetics in mood disorders.

Authors:  Patrick O McGowan; Tadafumi Kato
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

Review 3.  Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Authors:  Cristina Politi; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Neuromolecular Med       Date:  2018-01-05       Impact factor: 3.843

4.  Single Nucleotide Polymorphisms in SLC19A1 and SLC25A9 Are Associated with Childhood Autism Spectrum Disorder in the Chinese Han Population.

Authors:  Jun Liu; Weiming Mo; Zengyu Zhang; Hong Yu; Aiping Yang; Fei Qu; Pingfang Hu; Zhuo Liu; Shihu Wang
Journal:  J Mol Neurosci       Date:  2017-05-24       Impact factor: 3.444

5.  Genomic imprinting of Dopa decarboxylase in heart and reciprocal allelic expression with neighboring Grb10.

Authors:  Trevelyan R Menheniott; Kathryn Woodfine; Reiner Schulz; Andrew J Wood; David Monk; Andrew S Giraud; H Scott Baldwin; Gudrun E Moore; Rebecca J Oakey
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

Review 6.  Expanding the toolbox of ADHD genetics. How can we make sense of parent of origin effects in ADHD and related behavioral phenotypes?

Authors:  Tetyana Zayats; Stefan Johansson; Jan Haavik
Journal:  Behav Brain Funct       Date:  2015-10-16       Impact factor: 3.759

7.  Identifying new susceptibility genes on dopaminergic and serotonergic pathways for the framing effect in decision-making.

Authors:  Xiaoxue Gao; Jinting Liu; Pingyuan Gong; Junhui Wang; Wan Fang; Hongming Yan; Lusha Zhu; Xiaolin Zhou
Journal:  Soc Cogn Affect Neurosci       Date:  2017-09-01       Impact factor: 3.436

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.